Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: Who Should Do TEE in Structural Heart Cases?

December 28, 2023

News Daily News

Reusable Radiation Shield Cuts Operator Exposure by More Than 80%

L.A. McKeown

December 01, 2023

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

L.A. McKeown

November 17, 2023

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Shelley Wood

November 14, 2023

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

L.A. McKeown

October 12, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

Advertisement

Conversations in Cardiology: Who Should Do TEE in Structural Heart Cases?

Reusable Radiation Shield Cuts Operator Exposure by More Than 80%

High-Sensitivity Troponins May Overestimate PE Severity

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Approves Paradise Renal Denervation System: What Comes Next?

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content